In addition, both ALOX5 and IL5RA have been identified as susceptibility genes associated with asthma and asthmatic inflammation in humans [78, 79], and a monoclonal antibody to the IL5RA ligand, IL5, is FDA-approved for the treatment of severe eosinophilic asthma [80, 81]. The gene discussed is IL5; the disease is asthma.